It was observed that both the Tumor B and Tumor groups exhibited reduced levels of GZMB and IFN-γ (Figures 6A-D), indicating that IL-6 can diminish the effector killing capacity of CD8+ T cells. The gene discussed is GZMB; the disease is neoplasm.